S
SOLENO THERAPEUTICS INC
NASDAQ: SLNO (Soleno Therapeutics, Inc.)
Kemas kini terakhir: 2 jam lalu52.95
0.00 (0.00%)
| Penutupan Terdahulu | 52.95 |
| Buka | 52.94 |
| Jumlah Dagangan | 1,188,554 |
| Purata Dagangan (3B) | 3,364,851 |
| Modal Pasaran | 2,759,761,920 |
| Harga / Pendapatan (P/E TTM) | 135.77 |
| Harga / Pendapatan (P/E Ke hadapan) | 13.12 |
| Harga / Jualan (P/S) | 10.06 |
| Harga / Buku (P/B) | 5.57 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Aug 2026 |
| EPS Cair (TTM) | -4.74 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 22.73% |
| Nisbah Semasa (MRQ) | 19.64 |
| Aliran Tunai Operasi (OCF TTM) | -89.32 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -33.98 M |
| Pulangan Atas Aset (ROA TTM) | -52.40% |
| Pulangan Atas Ekuiti (ROE TTM) | -105.54% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Soleno Therapeutics, Inc. | Bercampur | Menurun |
AISkor Stockmoo
-0.3
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 0.0 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | NA |
| AI Insight | NA |
| Purata | -0.33 |
|
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 1.83% |
| % Dimiliki oleh Institusi | 109.24% |
AI Analisis Teknikal
Buka tab Teknikal untuk menjana analisis terkini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |